Adagio Therapeutics (ADGI) Announces Expansion of Management Team and Board of Directors

Adagio Therapeutics, Inc., (Nasdaq: ADGI) a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential, today announced that...
Login to comment.